Psychiatry · Medical Literature
High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?
Abstract
Ketamine is a fast-acting intervention for treatment-resistant depression (TRD), yet only a subset of patients show robust clinical response, and the underlying neural mechanisms remain unclear. High-order interactions (HOI) derived from multivariate information theory provide a framework for examining nonlinear dependencies among brain regions beyond pairwise connectivity. One such metric, the O-information, captures the balance between synergistic and redundant interactions across three or more variables. In this secondary analysis of a randomized, double-blind, midazolam-controlled trial (NCT02556606), we examined EEG-derived HOI in 30 late-life veterans with TRD following a single 40-minute intravenous infusion of ketamine (0.1, 0.25, 0.5 mg/kg; n = 18) or midazolam (0.03 mg/kg; n = 12). Resting state and mismatch negativity data were analyzed at baseline, 1 h, 24 h, and 7 d post-infusion. Ketamine induced temporally dynamic alterations in redundancy-dominant O-info, with maximal effects in the alpha-band at 1 h (Cohen's d = 2.57), attenuation at 24 h that shifted toward the theta-band, and partial resurgence in beta and gamma by Day 7. Linear mixed-effects modeling identified significant group effects across most band x metric families, with the strongest effects in alpha, beta, and gamma redundancy. Greater increases in 24-hour alpha-band redundancy were associated with greater improvement in depressive symptoms at Day 7 (β = 69.31, q = 0.05). HOI metrics also tracked acute dissociative states, with several 24-hour alpha and beta features remaining positively associated with symptom severity after correction. These findings extend prior HOI work in healthy samples to a controlled TRD cohort and suggest that ketamine induces temporally structured reorganization of higher-order brain interactions, with exploratory associations to clinical outcomes.
Clinical relevance
Do EEG-derived high-order interactions (O-information), measured across multiple time points following a single intravenous ketamine infusion, function as neural markers of antidepressant response in late-life veterans with treatment-resistant depression? __SNAPSHOT__ {"studyDesign":"Secondary analysis of a randomized, double-blind, active-comparator-controlled trial (NCT02556606); Bayesian adaptive randomization design","setting":"U.S. Veterans Affairs / academic medical center (Baylor College of Medicine / Michael E. DeBakey VA Medical Center, Houston, TX); inpatient/outpatient infusion setting","sampleSize":"n=30 total (ketamine: n=18 across three dose levels; midazolam: n=12)","population":"Late-life U.S. military veterans with treatment-resistant depression (LL-TRD); age group consistent with older adults (≥55 years); specific demographic breakdown not reported in abstract","intervention":"Single 40-minute IV infusion of ketamine at one of three sub-anesthetic doses: 0.1, 0.25, or 0.5 mg/kg; EEG-derived high-order interactions (O-information) computed from resting-state and mismatch negativity (MMN) paradigms","comparator":"Single 40-minute IV infusion of midazolam 0.03 mg/kg (active psychoactive control)","primaryOutcome":"EEG-derived O-information (HOI metric capturing balance of synergistic vs. redundant brain interactions across frequency bands); association with depressive symptom change (MADRS score) at Day 7 post-infusion","followUp":"Assessments at baseline, 1 hour, 24 hours, and 7 days post-infusion","fundingSource":"Not reported in abstract; parent trial (NCT02556606) was conducted at a VA medical center, suggesting federal/government funding; industry sponsorship not reported"}
Key findings
Ketamine induced temporally dynamic alterations in redundancy-dominant O-information. The largest acute effect was observed in the alpha band at 1 hour post-infusion (Cohen's d = 2.57, as reported in the abstract), representing a very large effect size. Effects attenuated by 24 hours, with a shift toward the theta band at that time point. Critically, greater increases in 24-hour alpha-band redundancy were associated with greater improvement in depressive symptoms at Day 7 (β = 69.31, q = 0.05), suggesting a potential biomarker signal for clinical response. HOI metrics also tracked acute dissociative states, with several 24-hour alpha and beta features remaining positively associated with symptom severity after correction for multiple comparisons. No formal NNT/NNH was calculable from the abstract data. Confidence intervals and specific p-values for most comparisons were not reported in the abstract beyond the q-value noted above.
Practice implications
This study establishes that a single sub-anesthetic ketamine infusion produces large, time-varying reorganization of high-order EEG brain interactions in older veterans with TRD — a finding that extends prior HOI research in healthy samples to a controlled clinical cohort. The exploratory association between 24-hour alpha-band redundancy and Day 7 depressive symptom improvement is hypothesis-generating but cannot be interpreted as a validated predictive biomarker; the q-value of 0.05 indicates this finding only marginally survived false-discovery-rate correction in a small sample. The study does not establish that HOI-guided patient selection or dosing improves clinical outcomes. Results apply specifically to late-life male veterans with TRD and should not be generalized to younger patients, non-veteran populations, women, or patients receiving repeated infusions. The three ketamine dose arms were pooled under a single 'ketamine' group for this secondary HOI analysis, preventing dose-response conclusions. Given this is a secondary analysis of an exploratory nature with only abstract-level data available for this review, clinical practice should not change based on these findings alone. __LIMITATIONS__ Very small sample (n=30 total; n=18 ketamine, n=12 midazolam), severely limiting statistical power and generalizability,Secondary/exploratory analysis of an existing RCT — not pre-specified as a primary aim, raising risk of type I error despite FDR correction,Ketamine administered at three different doses pooled into a single arm, obscuring dose-dependent HOI effects,Predominantly or exclusively male veteran population with late-life TRD markedly limits external validity to other demographic groups,Only abstract available for this review; full methods, complete statistical results, and adverse event data not assessable (noted as a critical limitation),EEG-derived O-information is a novel surrogate biomarker with no established clinical threshold for response prediction; clinical validity not yet determined,Unclear whether participants were blinded successfully to treatment allocation given the dissociative effects of ketamine versus midazolam,Short follow-up (7 days) prevents assessment of durability of both neural and clinical effects,Funding source and potential conflicts of interest not reported in the abstract, precluding assessment of sponsorship bias,Multiple comparisons across frequency bands and time points increase false-positive risk despite q-value correction __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ In 30 late-life veterans with TRD, a single IV ketamine infusion produced large, frequency-specific, time-varying changes in EEG high-order brain interactions, with 24-hour alpha-band redundancy showing an exploratory association with 7-day antidepressant response. These are preliminary, hypothesis-generating neurophysiological findings from a small secondary analysis and do not support changes to clinical practice. Replication in adequately powered, prospectively designed trials across diverse populations is required before HOI metrics can be considered clinically actionable biomarkers.